ESR1 and neoplasm: On the other hand, miR-107-5p and miR-222-3p targeting ERa and miR-205 targeting Estrogen Related Receptor Gamma (ESRRG) act as oncomiRNAs by enhancing migration, invasion in vitro or/and tumor growth in vivo [19,52,68].